Press release
Global Parkinson’s disease Drug Market Size, Share, Analysis, Industry Report and Forecast to 2025
A full Report of Global Parkinson’s Disease Drug Marketis Available at: https://www.omrglobal.com/industry-reports/parkinsons-disease-drug-market
Moreover, various research is also going on to find the exact cure for Parkinson’s disease which will significantly drive the Parkinson’s disease drug market. For instance, carbidopa-levodopa is the most effective drug used in Parkinson’s disease for the treatment of symptoms of Parkinson’s. However, as the disease progresses, the drugs starting to wear off in between doses. The symptoms of Parkinson’s disease come back or even cause excessive involuntary movements and the condition becomes more challenging to treat. This presents a major setback for the Parkinson’s disease drug market.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/parkinsons-disease-drug-market
To minimize the side effects of carbidopa-levodopa, the drug dosage is either adjust or use advanced therapies such as a combination of medications, or in some cases, deep brain stimulation is used. This expected to keep up Parkinson’s disease drug industry. However, all patients didn’t agree on deep brain stimulation or brain surgery. Therefore, UCMA has a device called Duopa pump that delivers medicine consistently throughout the day.
The duopa pump was FDA approved in 2015 and it is recently getting popular for use. Duopa is carbidopa-levodopa in a gel form. It is constantly administered to the patient using a small infusion pump that delivers the medication slowly all day long. The use of such devices prevents the body from receiving large doses of drugs at once, as it would if it were taken by mouth. Hence, the use of devices such as dopa pump is anticipated to drive the Parkinson’s disease drug market during the forecast period.
Parkinson’s disease is an incurable disorder that has proved various challenges in the process to manage and treat with the available drugs. Hence, disease symptom modification is the ultimate goal for the drug development of Parkinson's which is driving the market growth.
Global Parkinson’s Disease Drug Market- Segmentation
By Drug Class
• Dopamine Receptor Agonists
• MAO-Inhibitors
• Carbidopa-Levodopa
• Catechol O-methyltransferase (COMT) Inhibitors
• Anticholinergics
• Others
Global Parkinson’s Disease Drug Market-Segment by Region
North America
• US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East Africa
Company Profiles
• AbbVie Inc.
• ACADIA Pharmaceuticals Inc.
• Apotex Inc.
• Axovant Gene Therapies Ltd.
• Boehringer Ingelheim GmbH
• Bausch Health Companies Inc.
• Boston Scientific Corp.
• Cipla Inc.
• Daiichi Sankyo Espha Co., Ltd.
• Eli Lilly & Co.
• Eisai Co., Ltd.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline Plc
• Impax Laboratories, Inc.
• Merck & Co. Inc.
• Mylan NV
• Novartis International AG
• Orion Corp.
• Pfizer Inc.
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Vertical Pharmaceuticals, LLC
• Wockhardt Ltd.
For More Customized Data, Request for Report Customization @https://www.omrglobal.com/report-customization/parkinsons-disease-drug-market
For More Information, Visit https://www.omrglobal.com
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Parkinson’s disease Drug Market Size, Share, Analysis, Industry Report and Forecast to 2025 here
News-ID: 2133725 • Views: …
More Releases from Orion Market Research
Loader Buckets Market to see Huge Growth by 2028
Market experts do detailed market study about entire market from several angles to depict the most updated and key market data to form this detailed Loader Buckets Market research report and help startups to reinforce their presence. This report further aims at covering vital data and figures on major areas such Asia Pacific, North America, Middle East, Europe, Latin America and Africa. Business participants can also obtain larger gains as…
Probiotics Supplement Market Trends, Business Overview, Industry Growth and Fore …
The global probiotics supplement market is anticipated to grow at a significant CAGR of 7.2% during the forecast period (2022-2028). The rising consumer awareness for healthcare and fitness with rising disposable income, are likely to drive the market growth. Probiotics enable to maintenance of a healthy balance of gut flora and have been linked to a variety of health advantages, including weight loss, digestive health, and immunological function. The market…
Brick Pavers Market Top Leading Players with Strategies and Forecast 2028
Brick Pavers Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Brick Pavers market with a focus on the market. The report provides key statistics on market of Brick Pavers. It is a valuable source of guidance and direction for companies and individuals interested in Brick Pavers industry.
Key Players
Belgard
Acme Brick Company
The Belden Brick Company
Wienerberger
Pine Hall Brick
Redland Brick
By Type
General Brick Pavers
Wall…
Global Famciclovir Market Top Leading Players with Strategies and Forecast 2028
The global famciclovir market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Famciclovir is used to herpes zoster generally called shingle (a rash that can occur in people who have had chickenpox in the past). It's also used to treat persons with a healthy immune system who have recurrent herpes virus cold sores or fever blisters. The herpes simplex virus causes cold sores. When this virus enters the…
More Releases for Parkinson
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provide…
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold
Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global…
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a …
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life when…
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field.
After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most…
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease.
The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected…
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE
Become knowledgeable about the advancements in surgery
The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and…
